Skip to content
Government TAS, Medical Health Aged Care

Nation-leading partnered prescribing pilot to support Tasmanian aged care residents

Pharmaceutical Society of Australia (PSA) 2 mins read

Joining pharmacists on R U OK? Day, Tasmanian Health Minister Guy Barnett MP announced that Tasmanian pharmacists will soon be able to prescribe medicines for aged care patients under a new pilot program following the release of recommendations from the Review of Tasmanian Pharmacists’ Scope of Practice, which have been accepted by the state government in full.

The Tasmanian Health Minister also announced that patients will soon be able to access treatment for urinary tract infections (UTIs).

Pharmaceutical Society of Australia (PSA) Tasmanian President David Peachey MPS said the move demonstrated a commitment to improving accessible care for Tasmanians.

“I am proud to see the Tasmanian Government leading the nation on reform to best support aged care patients and our broader health system,” Mr Peachey said.

“It’s clear that we need to do more for our older Australians living in residential aged care. Allowing pharmacists to write repeat prescriptions or change the dose of an existing drug will free up hundreds of GP hours for complex and emerging needs.

“Pharmacists in many parts of Australia are already initiating treatment for uncomplicated UTIs, supporting safe, timely access to care for thousands of patients,” Mr Peachey said.

“Today’s announcement brings Tasmania in line with programs around the country.

“Pharmacists have shown that we can and should be doing more to improve patients’ access to care and strengthen the health system.”

Mr Peachey has also reaffirmed PSA’s support for expanding pharmacist scope of practice to better support Tasmanians. 

“The recommendations from the Scope of Practice review are a positive step toward a health system that works for patients.

“Recommendations from the review will make care more accessible for many Tasmanians, from structured prescribing to medication charting.

"This is recognition that pharmacists can and should do more as our most accessible health care professionals. This is particularly important as we mark R U OK? Day and the role that pharmacists can play in supporting patient's mental health. 

“PSA is committed to working collaboratively with the Health Minister and the Tasmanian Government to progress all recommendations as soon as possible.”

 

Media contact:   Georgia Clarke   M: 0480 099 798      E: [email protected]

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

Follow us on socials:      Facebook     Twitter      LinkedIn     Instagram

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.